DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Fimasartan
Fimasartan
Fimasartan Clinical Trial: Direction for Acute Myocardial Infarction
Cardioprotective Effect of Fimasartan, a New Angiotensin Receptor Blocker, in a Porcine Model of Acute Myocardial Infarction
Ehealth DSI [Ehdsi V2.2.2-OR] Ehealth DSI – Master Value Set
Use of Antitussives After the Initiation of Angiotensin-Converting Enzyme Inhibitors
Trends in the Market for Antihypertensive Drugs M
Drugs for Primary Prevention of Atherosclerotic Cardiovascular Disease: an Overview of Systematic Reviews
Clinical Characteristics and Satisfaction
Efficacy of Fimasartan/Hydrochlorothiazide Combination in Hypertensive Patients Inadequately Controlled by Fimasartan Monotherapy
Fimasartan, Anti-Hypertension Drug, Suppressed Inducible Nitric Oxide
Fimasartan, an Angiotensin II Receptor Antagonist, Ameliorates an in Vivo Zebrafish Model of Heart Failure
Hydrochlorothiazide 60/10/25 Mg and a Corresponding Loose Combination of Fimasartan/Amlodipine 60/25 Mg and Hydrochlorothiazide 25 Mg in Healthy Subjects
Effect of Angiotensin Converting Enzyme Inhibitor and Angiotensin II Receptor Blocker on the Patients with Sepsis
The Efficacy and Safety of Co-Administration of Fimasartan And
24-Hour Blood Pressure Response to Lower Dose (30 Mg) Fimasartan in Korean Patients with Mild to Moderate Essential Hypertension
Supplementary Information
Fimasartan Versus Perindopril With
Fimasartan, a Novel Angiotensin II Receptor Antagonist
Safety and Efficacy of Fimasartan with Essential Hypertension Patients In
Top View
UCSF UC San Francisco Previously Published Works
ATC-Index Mit DDD-Angaben Für Deutschland Im Jahre 2019
1 SUPPLEMENTAL MATERIAL Blood Pressure-Lowering Interventions To
Safety and Efficacy of Fimasartan in Mexican Patients with Grade 1–2
Beta-Blockers and Inhibitors of the Renin-Angiotensin Aldosterone System for Chronic Heart Failure with Preserved Ejection Fraction (Protocol)
Placental Transfer and Mammary Excretion of a Novel Angiotensin
Antihypertensive Efficacy of Fimasartan and Additional Benefits in Patients with Renal Dysfunction
Pharmacokinetic Comparison Between Fixed-Dose Combination Of
Fimasartan Attenuates Renal Ischemia-Reperfusion Injury By
The Proceedings of the 12Th Conference of the European Association for Clinical Pharmacology and Therapeutics
Safety and Efficacy of Fimasartan in Patients With
[Ehdsi V3.0.0-RC1] Ehealth DSI – Master Value Set Catalogue
An Application to Include Blood Pressure Lowering Drug Fixed Dose
Appendices: V Ervolgonderzoek Medicatieveiligheid
Fixed-Dose Combination Therapy for the Prevention of Atherosclerotic Cardiovascular Diseases (Review)
Supplementary Data (Tables and Figures)
Fimasartan, a Novel Angiotensin-Receptor Blocker
Access Document
A Multi-Objective Approach for Drug Repurposing in Preeclampsia
Hypertension in Adults: Diagnosis and Management E